The ISoP Standards and Best Practices Committee

Area of Science:

• Pharmacometrics
• Drug Development
• Clinical Pharmacology

Background:

• The International Society of Pharmacometrics (ISoP) Standards and Best Practices Committee was formed to address the need for standardized methodologies in pharmacometric analyses.
• Pharmacometric analyses, including population pharmacokinetics/pharmacodynamics (PK/PD), exposure-response modeling, and disease modeling, are crucial for drug development and decision-making.

Purpose of the Study:

• To outline the mission and ongoing progress of the ISoP Standards and Best Practices Committee.
• To propose recommendations for standardizing pharmacometric analyses to enhance consistency, productivity, quality, communication, and impact.
• To solicit volunteers to initiate and contribute to new standardization efforts.

Main Methods:

• The committee's work involves developing and disseminating best practices and recommendations for various pharmacometric analyses.
• Progress is reported through updates on ongoing initiatives and planned future activities.
• Volunteer recruitment is a key method for expanding the committee's capacity and scope.

Main Results:

• The committee has made progress in defining best practices for pharmacometric analyses.
• Specific areas of focus include population PK/PD, exposure-response, and disease models.
• A call for volunteers has been issued to drive new standardization initiatives.

Conclusions:

• Standardization of pharmacometric analyses is essential for improving the efficiency and impact of drug development.
• The ISoP committee is actively working towards establishing these standards.
• Engaging volunteers is critical for the successful implementation and expansion of these best practices.